Tech Company Financing Transactions
Alydia Health Funding Round
On 9/21/2018, Alydia Health raised $10 million in Series B funding from Global Health Investment Fund, Astia Angel and private investors.
Transaction Overview
Company Name
Announced On
9/21/2018
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors
Global Health Investment Fund (Lead Investor) (Curt LaBelle)
Astia Angel (Sharon Vosmek)
Proceeds Purpose
The Series B financing will support a U.S. pivotal study of the company's innovative technology designed to prevent the maternal morbidity and mortality caused by postpartum hemorrhage.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3495 Edison Way
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Not Recorded
Overview
In 2010, two biomedical engineering students at Cal Poly decided to enter a competition to design an improved PPH treatment. They set a goal of encouraging natural physiologic recovery, creating a device that was designed to work with the natural contraction of the uterus to rapidly stop bleeding. And so, vacuum-induced uterine tamponade was born.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Binney
Chief Operating Officer
Colby Holtshouse
VP - Marketing
Claudia Orellana
VP - Operations
Steve Lopez
VP - Operations
Kathryn Wine
VP - R & D
Vaishali Suraj
VP - R & D
Andrew Uchida
VP - Regulatory Affairs
Cindy Domecus
Browse more venture capital transactions:
Prev: 9/20/2018: Empower venture capital transaction
Next: 9/21/2018: Element Science venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs